RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $18,130,000 | +73.4% | 2,020,917 | +3.8% | 0.00% | +100.0% |
| Q2 2016 | $10,454,000 | +66.3% | 1,947,089 | +42.4% | 0.00% | 0.0% |
| Q1 2016 | $6,286,000 | -57.8% | 1,366,949 | -52.2% | 0.00% | -50.0% |
| Q4 2015 | $14,886,000 | -27.9% | 2,861,890 | -16.1% | 0.00% | 0.0% |
| Q3 2015 | $20,639,000 | -56.8% | 3,411,448 | +12.7% | 0.00% | -60.0% |
| Q2 2015 | $47,800,000 | +53.4% | 3,027,380 | +5.6% | 0.01% | +66.7% |
| Q1 2015 | $31,165,000 | -2.1% | 2,867,421 | -5.2% | 0.00% | 0.0% |
| Q4 2014 | $31,825,000 | +36.8% | 3,025,126 | +24.7% | 0.00% | 0.0% |
| Q3 2014 | $23,269,000 | -10.3% | 2,426,347 | +8.0% | 0.00% | 0.0% |
| Q2 2014 | $25,952,000 | +0.4% | 2,246,873 | -13.1% | 0.00% | 0.0% |
| Q1 2014 | $25,848,000 | -17.2% | 2,584,980 | -8.0% | 0.00% | +50.0% |
| Q4 2013 | $31,219,000 | +10.9% | 2,810,673 | +49.2% | 0.00% | -33.3% |
| Q3 2013 | $28,138,000 | +242.4% | 1,883,557 | +114.3% | 0.00% | +200.0% |
| Q2 2013 | $8,217,000 | – | 879,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|